Titelbild

Press releases

2017-08-22 – Press release

Topas Therapeutics signs multi-year research and option agreement with Lilly focused on immune tolerance

read more …

2017-04-04 – Press release

Paul Sekhri joins Topas Therapeutics as Chairman of the Board

read more …

2016-03-22 – Press release

Evotec spins off auto-immune disease company as ‘Topas Therapeutics GmbH’

  • Topas Therapeutics GmbH is based on a proprietary nanoparticle platform which supports antigen-specific tolerance induction for multiple indications
  • Strong consortium consisting of Epidarex Capital, EMBL Ventures, Gimv and Evotec AG supports strategic Series A financing round of EUR 14 m
  • Initiation of first clinical trials expected in 2017

read more …

2016-03-22 – Press release

Topas Therapeutics Raises EUR 14 Million to Treat Immunological Disorders

  • Causal therapies based on novel approach for antigen-specific tolerance induction
  • Significant opportunities through near term clinical proof-of-concept (“POC”)
  • Strong strategic syndicate includes Epidarex Capital, EMBL Ventures, Gimv, and Evotec AG

read more …